Co-targeting the kappa opioid receptor and dopamine transporter reduces motivation to self-administer cocaine and partially reverses dopamine system dysregulation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Co-targeting the kappa opioid receptor and dopamine transporter reduces motivation to self-administer cocaine and partially reverses dopamine system dysregulation ; volume:14 ; number:1 ; day:18 ; month:3 ; year:2024 ; pages:1-14 ; date:12.2024
Scientific reports ; 14, Heft 1 (18.3.2024), 1-14, 12.2024
- Urheber
-
Estave, Paige M.
Albertson, Steven E.
Karkhanis, Anushree N.
Jones, Sara R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-53463-9
- URN
-
urn:nbn:de:101:1-2405210840203.971965126618
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Estave, Paige M.
- Albertson, Steven E.
- Karkhanis, Anushree N.
- Jones, Sara R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dopamine-beta hydroxylase polymorphism and cocaine addiction
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
Regulation of dopamine-dependent transcription and cocaine action by Gadd45b
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
Dopamine devils
Expectation effects on brain dopamine responses to methylphenidate in cocaine use disorder
Cocaine reward and locomotion stimulation in mice with reduced dopamine transporter expression
Chronic ultraviolet irradiation induces memory deficits via dysregulation of the dopamine pathway
Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson’s disease
cAMP-mediated upregulation of HCN channels in VTA dopamine neurons promotes cocaine reinforcement
Predictors of dopamine dysregulation syndrome in patients with early Parkinson’s disease
Dopamine beta-hydroxylase deficiency
Dopamine-beta hydroxylase polymorphism and cocaine addiction
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
Regulation of dopamine-dependent transcription and cocaine action by Gadd45b
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
Dopamine devils
Expectation effects on brain dopamine responses to methylphenidate in cocaine use disorder
Cocaine reward and locomotion stimulation in mice with reduced dopamine transporter expression
Chronic ultraviolet irradiation induces memory deficits via dysregulation of the dopamine pathway
Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson’s disease
cAMP-mediated upregulation of HCN channels in VTA dopamine neurons promotes cocaine reinforcement
Predictors of dopamine dysregulation syndrome in patients with early Parkinson’s disease
Dopamine beta-hydroxylase deficiency
Dopamine-beta hydroxylase polymorphism and cocaine addiction
Successful treatment of dopamine dysregulation syndrome with dopamine D2 partial agonist antipsychotic drug
Regulation of dopamine-dependent transcription and cocaine action by Gadd45b
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
Dopamine devils
Expectation effects on brain dopamine responses to methylphenidate in cocaine use disorder
Cocaine reward and locomotion stimulation in mice with reduced dopamine transporter expression
Chronic ultraviolet irradiation induces memory deficits via dysregulation of the dopamine pathway
Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson’s disease
cAMP-mediated upregulation of HCN channels in VTA dopamine neurons promotes cocaine reinforcement
Predictors of dopamine dysregulation syndrome in patients with early Parkinson’s disease